Supplementary Figure S3 from Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy
James N. Ingle(Mayo Clinic), Liewei Wang(Mayo Clinic), Matthew P. Goetz(Mayo Clinic), Yoichi Furukawa(The University of Tokyo), Paul E. Goss(Harvard University), Erin E. Carlson(University of Minnesota), Bingshu E. Chen(University of Iowa), Poulami Barman, Matthew J. Ellis(University of California, Davis), Kathleen I. Pritchard, Richard M. Weinshilboum(Mayo Clinic), Vered Stearns(Johns Hopkins University), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Krishna R. Kalari(Mayo Clinic in Florida), Fang Xie, Yukihide Momozawa(RIKEN Center for Integrative Medical Sciences), Judith‐Anne W. Chapman(Queen's University), Lois E. Shepherd(Ontario Institute for Cancer Research)
Cited by 0
Related Papers
Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking
|Nature Biotechnology|2016|4.7k
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k